SCHEMBL6826880

SCHEMBL6826880

Nc1nccc(-c2ccnc(N)c2-c2ccc(C(F)(F)F)cc2)c1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.47
HEXA P06865 1/20 0.45
HEXB P07686 1/20 0.45
USP7 Q93009 1/20 0.43
NOS3 P29474 1/20 0.43
NOS2 P35228 1/20 0.43
SRC P12931 1/20 0.43
BRAF P15056 1/20 0.43
KDR P35968 1/20 0.43
RPS6KB1 P23443 6/20 0.41
TLR7 Q9NYK1 1/20 0.41
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
MAP4K4 O95819 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3243063 0.82 KIF11 (0.47) KIF11HEXAHEXBNOS3NOS2
SCHEMBL29888283 0.75 MKNK1 (0.54) KIF11KDRTLR7MAP4K4MKNK1
SCHEMBL30544068 0.74 KIF11 (0.50) KIF11HEXAHEXBNOS3NOS2
SCHEMBL27856886 0.74 KIF11 (0.50) KIF11HEXAHEXBNOS3NOS2
SCHEMBL6826885 0.74 NOS3 (0.46) KIF11HEXAHEXBUSP7NOS3
SCHEMBL25250732 0.71 KIF11 (0.47) KIF11HEXAHEXBUSP7CCNB2
SCHEMBL29013658 0.70 KIF11 (0.60) KIF11HEXAHEXBMKNK1MKNK2
SCHEMBL29360194 0.69 GSK3B (0.46) HEXAHEXBUSP7NOS3NOS2
SCHEMBL4647645 0.69 GSK3B (0.46) HEXAHEXBUSP7NOS3NOS2
SCHEMBL14553725 0.69 TOP2A (0.60) KIF11CCNB2CDK1CCNB1GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004052880-A1 PYRIDINE DERIVATIVES AS JNK INHIBITORS AND THEIR USE ASTRAZENECA AB (SE) 2004-06-24 WO disclosed